Dr Mark Donohoe is one of Australia's most experienced medical practitioners in the fields of nutritional and environmental medicine and integrative medicine.
Mark graduated from the Faculty of Medicine at Sydney University in 1980 and has worked in private practice since 1983. Mark uses orthodox and complementary modalities to treat patients with complex, chronic conditions, including CFS/ME, fibromyalgia and chemical sensitivities.
Mark has specialised in environmental and nutritional medicine for 28 years, is a Fellow of ACNEM, and in 1994 was elected founding president of the Australian Comprehensive Medicine Association, which has since become the Australian Integrative Medicine Association. From 2004 to 2010, he was founding president of the Natural Health Care Alliance, a national body representing the Natural Healthcare / Complementary Medicine profession.
Mark and other medical colleagues experienced in integrative medicine have established the Centre for Evidence-Based Complementary Medicine, a private venture committed to building the evidence-base for natural, complementary and integrative medicine approaches to prevention and treatment of disease. Mark's goal is to extract the best and most clinically relevant complementary medicine research to support integrative medicine practitioners and improve health outcomes for all Australians.
Anthony Linnane was Professor of Biochemistry at Monash University from 1965 to 1994 and Director of the Centre for Molecular Biology and Medicine from 1983 to 1996. He continued as Director of the Centre from 1996, when it became an independent corporation.
Anthony was educated at the Universities of Sydney and Wisconsin (MSc, PhD 1956, DSC 1972). He was a postdoctoral fellow at the University of Wisconsin from 1956 to 1958 and then returned to the University of Sydney as a senior lecturer in the Department of Biochemistry from 1959 to 1962. Anthony was also the founder and director of Mabtech Ltd 1994, a centre for Molecular Biology and Medicine. In 2000 he and his team were awarded the Distinguished Service Award by the International Union of Biochemistry and Molecular Biology.
Matthew is a clinical psychologist. He gained his PhD at the University of Queensland where he holds an academic position at the School of Medicine. He coordinates the postgraduate mental health programs.
Matthew has published extensively in the area of evidence based treatments. He has a strong track record in conducting clinical treatment trials and has made internationally recognised contributions to psychological treatments for major depressive disorder and novel online treatment delivery modalities. In 2014 Matthew coauthored with Luis Vitetta and Hollie Alford, 'The gastrointestinal tract microbiome, probiotics, and mood' , published in the journal Inflammopharmacology.
Matthew's current active research interests include researching effectiveness and mechanisms of action in integrative medicine approaches to resistant depression that are nonresponsive to best standard treatments.
Matthew also has active e-health projects in child behaviour management and in the assessment and treatment of mental health patients in rural and remote areas in Australia.
Head of Cancer Cell Immortality Laboratory at the University of NSW, Prince of Wales Clinical School
Jeremy has 14 years experience in cancer research and notably predicted the presence of a completely novel type of cancer biomarker and invented (patented) an assay to detect it. The assay has the potential to become a clinically useful diagnostic tool and a research tool for the discovery of novel ALT-targeted therapeutics.
Jeremy maintains his clinical practise, and is a Career Medical Officer at St Luke's Hospital, the Hospital for Specialist Surgery and Westmead Private Hospital.
Jeremy also lectures and teaches at the UNSW Faculty of Medicine and contributes to journal review, research grant review, PhD student review and bio-banking committees.